APA Alıntı

Dahan, R., Barnhart, B. C., Li, F., Yamniuk, A. P., Korman, A., & Ravetch, J. V. (2016). Therapeutic activity of agonistic, human anti-CD40 monoclonal Abs requires selective FcγR-engagement. Cancer Cell.

Chicago Stili Alıntı

Dahan, Rony, Bryan C. Barnhart, Fubin Li, Aaron P. Yamniuk, Alan Korman, ve Jeffrey V. Ravetch. "Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Abs Requires Selective FcγR-engagement." Cancer Cell 2016.

MLA Alıntı

Dahan, Rony, et al. "Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Abs Requires Selective FcγR-engagement." Cancer Cell 2016.